Details of the Drug Combination

General Information of Drug Combination (ID: DCDHS4Z)

Drug Combination Name
Zinc Sulfate Azithromycin
Indication
Disease Entry Status REF
COVID-19 Phase 4 [1]
Component Drugs Zinc Sulfate   DM9AJRB Azithromycin   DMS6UOE
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL is unavailable 3D MOL is unavailable

References

1 ClinicalTrials.gov (NCT04370782) Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Azithromycin FDA Label
4 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 065511.
5 ClinicalTrials.gov (NCT04332107) Azithromycin for COVID-19 Treatment in Outpatients Nationwide. U.S. National Institutes of Health.